Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
ENTITY
Samsung Biologics (207940 KS)
Watchlist
330
Analysis
Health Care
•
South Korea
Samsung Biologics Co.,Ltd. manufactures bio-healthcare products. The Company develops, refines, and distributes biopharmaceutical products.
more
Watchlist
All
Insights
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bearish
•
Quantitative Analysis
•
13 Dec 2023 07:00
KRX Short Interest Weekly (Dec 8th): Naver
We analyzed the KRX short interest report for the past week and we highlighted weekly KRX short interest changes in Naver.
Ke Yan, CFA, FRM
Follow
370 Views
Share
bullish
•
LG CNS
•
08 Dec 2023 07:21
2024 Major IPOs Pipeline in Korea
This insight will feature 50 of the biggest potential IPOs in Korea in 2024. This is our 9th "Annual Edition of the Major Korean IPOs Pipeline...
Douglas Kim
Follow
835 Views
Share
bearish
•
Wuxi Biologics
•
04 Dec 2023 21:53
Wuxi Biologics (2269 HK): Lowered 2023 Revenue Expectation Amid Challenging Industry Outlook
Wuxi Biologics expects 2023 revenue will miss by $400M due to reduced number of projects amid industry slowdown. New capacity ramp up, together...
Tina Banerjee
Follow
448 Views
Share
bearish
•
Quantitative Analysis
•
15 Nov 2023 11:22
KRX Short Interest Weekly (Nov 10th): Short Covers for LG Energy, Kakao, Krafton, Amorepacific
We analyzed KRX short interest report for the past week and highlight short interest changes in Medytox, Lg Energy Solution, Kakao, Krafton,...
Ke Yan, CFA, FRM
Follow
293 Views
Share
bullish
•
Wuxi Biologics
•
05 Nov 2023 08:25
ECM Weekly (5th Nov 2023)- Midea, WuxiXDC, Cello, Honasa, Qyuns, Ecopro, Lalatech, Mankind, TWE, VNT
Aequitas Research puts out a weekly update on the deals that were covered by the team recently along with updates for upcoming IPOs.
Sumeet Singh
Follow
410 Views
Share
First
Previous
12
13
14
15
16
17
18
Next
Last
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.40.5
x